Exponent Inc. (EXPO) Receives Consensus Rating of “Hold” from Analysts
Shares of Exponent Inc. (NASDAQ:EXPO) have received a consensus broker rating score of 2.50 (Hold) from the four analysts that provide coverage for the stock, Zacks Investment Research reports. Three investment analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company. Exponent’s rating score has improved by 16.7% from 90 days ago as a result of a number of analysts’ ratings changes.
Brokerages have set a 12 month consensus price objective of $50.33 for the company and are expecting that the company will post $0.36 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Exponent an industry rank of 175 out of 265 based on the ratings given to its competitors.
A number of research analysts have recently weighed in on the company. Zacks Investment Research upgraded Exponent from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 20th. Cantor Fitzgerald assumed coverage on Exponent in a report on Friday, August 26th. They issued a “buy” rating and a $57.00 target price on the stock. Finally, Avondale Partners started coverage on Exponent in a report on Thursday, July 7th. They issued a “market perform” rating and a $60.00 target price on the stock.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/17/exponent-inc-expo-receives-consensus-rating-of-hold-from-analysts.html
In related news, insider Paul Boehm sold 5,000 shares of Exponent stock in a transaction on Tuesday, August 16th. The stock was sold at an average price of $52.18, for a total transaction of $260,900.00. Following the sale, the insider now directly owns 24,045 shares in the company, valued at $1,254,668.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.50% of the company’s stock.
A number of hedge funds have recently modified their holdings of EXPO. Vanguard Group Inc. raised its stake in shares of Exponent by 3.9% in the second quarter. Vanguard Group Inc. now owns 2,004,471 shares of the company’s stock worth $117,081,000 after buying an additional 75,731 shares during the period. BlackRock Fund Advisors increased its stake in Exponent by 2.4% in the second quarter. BlackRock Fund Advisors now owns 1,631,643 shares of the company’s stock worth $95,304,000 after buying an additional 38,240 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC increased its stake in Exponent by 0.5% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,472,728 shares of the company’s stock worth $86,022,000 after buying an additional 7,610 shares in the last quarter. Atlanta Capital Management Co. L L C increased its stake in Exponent by 4.4% in the second quarter. Atlanta Capital Management Co. L L C now owns 920,771 shares of the company’s stock worth $53,782,000 after buying an additional 38,882 shares in the last quarter. Finally, BlackRock Institutional Trust Company N.A. increased its stake in Exponent by 0.6% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 644,090 shares of the company’s stock worth $32,855,000 after buying an additional 3,931 shares in the last quarter. Institutional investors and hedge funds own 91.57% of the company’s stock.
Shares of Exponent (NASDAQ:EXPO) traded up 0.99% on Monday, reaching $49.18. The company’s stock had a trading volume of 36,265 shares. The stock has a market cap of $1.28 billion, a P/E ratio of 28.10 and a beta of 0.85. The firm’s 50 day moving average is $50.08 and its 200-day moving average is $51.89. Exponent has a 52-week low of $44.82 and a 52-week high of $59.71.
Exponent (NASDAQ:EXPO) last posted its earnings results on Tuesday, July 19th. The company reported $0.38 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.43 by $0.05. Exponent had a net margin of 15.13% and a return on equity of 16.02%. The company earned $77.30 million during the quarter, compared to the consensus estimate of $80.46 million. On average, equities research analysts forecast that Exponent will post $1.59 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, September 23rd. Investors of record on Friday, September 2nd were issued a dividend of $0.18 per share. The ex-dividend date was Wednesday, August 31st. This represents a $0.72 dividend on an annualized basis and a yield of 1.48%. Exponent’s dividend payout ratio (DPR) is currently 41.62%.
Exponent Company Profile
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.